Johnsen J, Mørland J
Incognito Klinikk, Statens rettstoksikologiske institutt, Oslo.
Tidsskr Nor Laegeforen. 1990 Apr 10;110(10):1229-30.
The therapeutic rationale for using implanted disulfiram is possible inhibition of the liver enzyme acetaldehyde dehydrogenase, producing an acetaldehyde-mediated aversive reaction after intake of ethanol. Several studies using volunteers and patients in a double blind controlled study produced no evidence that a disulfiram implant (1 g) has any significant pharmacological or clinical action, except for a higher frequency of local surgical complications.
使用植入式双硫仑的治疗原理可能是抑制肝脏酶乙醛脱氢酶,在摄入乙醇后产生乙醛介导的厌恶反应。多项针对志愿者和患者的双盲对照研究没有证据表明双硫仑植入物(1克)有任何显著的药理或临床作用,除了局部手术并发症的发生率较高。